Zoledronic acid combined with androgen-deprivation therapy may prolong time to castration-resistant prostate cancer in hormone-naïve metastatic prostate cancer patients – A propens...

por Nagao, Kazuhiro, Matsuyama, Hideyasu, Nozawa, Masahiro, Hara, Isao, Nishioka, Tsukasa, Komura, Takahiro, Esa, Atsunobu, Uejima, Shigeya, Imanishi, Masaaki, Uekado, Yasunari, Ogawa, Takatoshi, Kajikawa, Hiroshi, Uemura, Hirotsugu
Publicado 2016

Comparison of Abiraterone and Combined Androgen Blockade Therapy for High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Propensity Score-Matched Analysis

por Matsumura, Naoki, Fujita, Kazutoshi, Nishimoto, Mitsuhisa, Yamamoto, Yutaka, Kuwahara, Ken, Nagai, Yasuharu, Minami, Takafumi, Hatanaka, Yuji, Nozawa, Masahiro, Morimoto, Yasuhiro, Tahara, Hideo, Uejima, Shigeya, Esa, Atsunobu, Hirayama, Akihide, Yoshimura, Kazuhiro, Uemura, Hirotsugu
Publicado 2021